GlassScriptPhysician profile
Suzanne R Lesage
NPI 1356386569
$4,257.46
in general payments reported to CMS, 2019-2025
18 companies · $2,410 in 2025
The $2,410 reported for 2025 was more than what 75% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $56.82 · 2021: $133 · 2022: $193 · 2023: $46.68 · 2024: $1,232 · 2025: $2,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,872 · Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,871.82 |
| Food and Beverage | $816.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,665.71 | 2021-2025 | Infinity, Proclaim |
| Inspire Medical Systems, INC. | $1,125.56 | 2023-2025 | Inspire |
| Livanova USA, INC. | $79.96 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Neurocrine Biosciences, INC. | $51.27 | 2019-2021 | |
| Lilly USA, LLC | $49.51 | 2019 | |
| Lundbeck LLC | $34.44 | 2020-2025 | Vyepti |
| Medtronic, INC. | $34.25 | 2024 | Percept PC Brainsense |
| Celgene Corporation | $32.19 | 2024 | Zeposia |
| Mdd US Operations, LLC | $25.75 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $22.84 | 2021 | |
| Kyowa Kirin, INC. | $22.83 | 2021 | |
| Insightec,INC | $22.62 | 2025 | Exablate |
| Genentech USA, INC. | $19.05 | 2020 | |
| Ucb, INC. | $17.38 | 2019 | |
| Biogen, INC. | $14.46 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $14.20 | 2019 | |
| Allergan, INC. | $13.59 | 2019 | |
| Genzyme Corporation | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Lesage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.